Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval.
Donegan DM, Pivonello R, Stigliano A, Lardo P, Kearney T, Mezősi E, Ghigo E, Giordano R, Mariash CN, Feelders RA, Donaldson K, Darpo B, Xue H, Custodio JM, Hand AL, Moraitis AG. Donegan DM, et al. Among authors: custodio jm. Endocr Pract. 2024 Jan;30(1):11-18. doi: 10.1016/j.eprac.2023.09.011. Epub 2023 Oct 5. Endocr Pract. 2024. PMID: 37805100 Free article.
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study.
Colombo N, Van Gorp T, Matulonis UA, Oaknin A, Grisham RN, Fleming GF, Olawaiye AB, Nguyen DD, Greenstein AE, Custodio JM, Pashova HI, Tudor IC, Lorusso D. Colombo N, et al. Among authors: custodio jm. J Clin Oncol. 2023 Oct 20;41(30):4779-4789. doi: 10.1200/JCO.22.02624. Epub 2023 Jun 26. J Clin Oncol. 2023. PMID: 37364223 Free PMC article. Clinical Trial.
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.
Munster PN, Greenstein AE, Fleming GF, Borazanci E, Sharma MR, Custodio JM, Tudor IC, Pashova HI, Shepherd SP, Grauer A, Sachdev JC. Munster PN, et al. Among authors: custodio jm. Clin Cancer Res. 2022 Aug 2;28(15):3214-3224. doi: 10.1158/1078-0432.CCR-21-4363. Clin Cancer Res. 2022. PMID: 35583817 Free PMC article. Clinical Trial.
Cyclohexanone-Based Chalcones as Alternatives for Fuel Additives.
Sallum LO, Duarte VS, Custodio JMF, Faria ECM, da Silva AM, Lima RS, Camargo AJ, Napolitano HB. Sallum LO, et al. Among authors: custodio jmf. ACS Omega. 2022 Mar 31;7(14):11871-11886. doi: 10.1021/acsomega.1c07333. eCollection 2022 Apr 12. ACS Omega. 2022. PMID: 35449976 Free PMC article.
Halogen bonds on substituted dibromonitrobenzene derivatives.
Ternavisk RR, Duarte VS, Custódio JMF, Hernández GA, Romero JA, Camargo AJ, Napolitano HB. Ternavisk RR, et al. Among authors: custodio jmf. J Mol Model. 2020 Oct 26;26(11):319. doi: 10.1007/s00894-020-04566-3. J Mol Model. 2020. PMID: 33104901
40 results